semaglutide sugar GLP-1 Treatment Specialist Semaglutide GLP-1 for Medical Weight

Weight loss expectations: In landmark trials such as STEP 1 (Semaglutide Treatment Effect in People with obesity) and SCALE (Satiety and Clinical Adiposity Liraglutide Evidence), participants achieved average weight reductions of 14.9% of initial body weight over 68 weeks with semaglutide 2.4 mg weekly, and approximately 8% with liraglutide 3.0 mg daily

After opening, semaglutide remains usable for 28 days if refrigerated continuously

J Clin Invest (2016) 126(5):16309

Some may notice changes sooner than others depending on metabolism, lifestyle, and medical history

Petersburg, Florida, individuals with a BMI of 30 or more, or those with a BMI of 27 or above accompanied by a related condition like hypertension or sleep apnea, might qualify for treatment through Klinic